Glucocorticoid-associated maternal hyperglycemia: A randomized trial of insulin prophylaxis

✍ Scribed by Jami Star; Joseph Hogan; Mary Ellen Burke Sosa; Marshall W. Carpenter

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 130 KB
• Volume: 9
• Category: Article
• ISSN: 1057-0802
• DOI: 10.1002/1520-6661(200009/10)9:5<273::aid-mfm3>3.0.co;2-n

✦ Synopsis

Objectives:

To study the degree and timing of maternal hyperglycemia following betamethasone therapy in nondiabetic patients and establish a prophylactic dose of insulin.

Methods:

Forty-five patients receiving betamethasone 12 mg i.m. at 7 am on two consecutive days were randomized to no insulin (n = 20), low-dose insulin (n = 18), and high-dose insulin (n = 7) protocols. each treatment group received s.c. insulin at 7 am on the 2 days of betamethasone therapy (20 units nph/10 units regular, and 40 units nph/20 units regular, respectively). capillary plasma glucose measurements were obtained at fasting and 2 h after meals for 3 days. a multivariate normal regression model was used to estimate and compare mean glucose levels.

Results:

Eighty-five percent of patients who did not receive insulin exhibited hyperglycemia at levels previously associated with fetal acidosis. significant differences in mean postprandial plasma glucose levels were found between the no-treatment and insulin groups on days 1 and 2. no significant differences were noted between groups on day 3.

Conclusions:

Transient maternal hyperglycemia occurs in a consistent pattern in nondiabetic patients receiving betamethasone, which can be limited by the concurrent use of insulin. further studies to assess fetal acidosis in this setting are warranted.